Objective To delineate the electroclinical features of SCN8A infantile developmental and epileptic encephalopathy (EIEE13, OMIM #614558).
SCN8A encodes the pore-forming voltage-gated sodium channel subunit Nav1.6, which is widely expressed in the brain. 1 Pathogenic variants in SCN8A result in impaired channel inactivation, causing neuronal hyperexcitability, seizures, and neurocognitive problems. 2 In humans, pathogenic SCN8A variants are associated with a wide spectrum of epilepsy phenotypes, spanning from benign familial infantile seizures 3, 4 to mild-to-severe developmental and epileptic encephalopathies. [5] [6] [7] [8] [9] [10] Early infantile epileptic encephalopathy type 13 (EIEE13, OMIM #614558) is a recently recognized syndrome caused by de novo SCN8A missense variants. 2, 11 Clinical features include developmental impairment, which is usually severe, although at times milder, pyramidal and extrapyramidal signs, and epilepsy. 9 Seizures start before 18 months of age and are intractable, although may improve with sodium channel-blocking antiepileptic drugs (AEDs). Multiple seizure types occur, including focal seizures (FS), generalized seizures, and epileptic spasms. 12 In a previous report, we described a heterogeneous spectrum of epilepsies related to variants in SCN8A and emphasized the peculiar interictal EEG abnormalities in some patients. 9 SUDEP (sudden unexpected death in epilepsy) is reported in approximately 10% of cases. 2, 9, 10, 13 Since the same SCN8A variant can lead to different clinical scenarios, 13 phenotyping is crucial in informing prognosis. With this study, we sought to further characterize the interictal and ictal electroclinical phenotype in a large homogeneous cohort of patients with severe SCN8A developmental and epileptic encephalopathy (SCN8A-DEE).
Methods
Through an international collaboration including clinical epilepsy centers in Europe, the United States, and Australia, we collected patients with epileptic encephalopathy due to SCN8A variants. Clinical information was collected retrospectively and prospectively by face-to-face interviews with patients and their families and from clinical charts. The referring clinicians provided a detailed phenotyping table, contacting the families in case of missing information.
Neurophysiologic and imaging investigations
Video-EEG recordings were available for 20 of 22 patients at epilepsy onset and all patients at follow-up. EEGs were obtained by a digital acquisition system, placing scalp electrodes according to the 10-20 international system. Selected patients underwent video-polygraphic investigations (EEG, ECG, and EMG traces). In 20 patients, ictal EEG recordings were available, and for the remaining 2 patients, EEG reports were obtained. A single epileptologist with EEG expertise (E.G.) reviewed 97 EEGs (1-12 EEGs per patient, with a follow-up of 10-56 months, including long-term monitoring video-EEGs) for background activity, interictal epileptiform abnormalities, ictal EEG discharges, and clinical manifestations. For 8 patients, an overnight video-EEG was available, and a visual assessment of sleep macrostructure was performed. In selected patients (6, 15, and 17) , the interictal and ictal EEG underwent offline analysis, namely, source analysis and dipole localization using the brain electrical source analysis program (BESA GmbH, Gräfelfing, Germany). Electroretinograms, visual evoked potentials, somatosensory evoked potentials, and nerve conduction studies were performed in 4, 7, 4, and 2 patients, respectively. Brain MRI data were obtained from all patients (1-4 scans each), including MRI spectroscopy in 6.
Standard protocol approvals, registrations, and patient consents Written informed consent, including authorization for reproduction of video images, was obtained for all patients and family members where necessary. Patient data were collected according to guidelines of their country's research ethics committee.
Data availability
Anonymized data that support the findings of this study are available from the corresponding author (E.G.) on reasonable request. Not all of the data are publicly available because they contain information that could compromise children's privacy and their family consent.
Results
We collected the electroclinical data of 17 unpublished and 5 previously published patients. The patients with published data had previously been described in less detail.
The cohort included 11 males and 11 females whose ages ranged from 19 months to 22 years (table 1) . None of the patients had a similarly affected family member; however, 6 patients (4, 6, 11, 15, 20, 21) had a family history of epileptic seizures in 1 or 2 first-or second-degree relatives who did not carry an SCN8A mutation. All but one (patient 20) were born at term; none had experienced a perinatal insult.
Epilepsy
Median age at epilepsy onset was 4 months (range: 0.5-36 months) (table 1) . One child (patient 3) had increased fetal movements, reminiscent of seizures, and one (patient 15) had Glossary AED = antiepileptic drug; DEE = developmental and epileptic encephalopathy; EIEE13 = early infantile epileptic encephalopathy type 13; FS = focal seizures; NCSE = nonconvulsive status epilepticus; SUDEP = sudden unexpected death in epilepsy; TCS = tonic-clonic seizure. myoclonic jerks from birth. The most common seizure types at epilepsy onset were tonic, tonic-vibratory, and tonic-clonic (18/22), often asymmetric or lateralized (7/22) , and preceded by cyanosis or autonomic features (9/22). One patient (7) had nonconvulsive status epilepticus (NCSE) at epilepsy onset. Two patients debuted with subsequent "convulsive" afebrile seizure (15, 22) and 2 had epileptic spasms with hypsarrhythmia at onset (2, 4 Epilepsy, cognitive decline, and neurologic signs had a stormy onset and progressive worsening in 16 of 22 patients (73%). The remaining 6 children (27%) followed a more gradual course, with periods of stagnation and regression associated with increased seizure frequency, alternating with partial recovery during seizure-free periods.
Four patients (18%) (3, 13, 17, 21) died between age 22 months and 5 years 6 months. Before dying, all 4 had uncontrolled seizures and progressive severe neurologic deterioration; 3 succumbed to a lower respiratory tract infection (3, 13, 21) . Patient 17 died in a terminal phase of her disease, after extreme worsening of her epilepsy and general condition the last year of life. Among older patients, aged 6-22 years (10/22), 8 stabilized or improved overall with age, with better seizure control, from age 5 to 9 years. One child (9), with stormy epilepsy onset at the age of 4 months, showed a milder evolution from 2 years of age.
EEG and other neurophysiologic investigations
Interictal EEG at epilepsy onset was normal in 7 of 20 patients (35%), showed discrete slowing and infrequent epileptiform abnormalities in 10 (40%), hypsarrhythmia in 2, and NCSE in one. All patients developed progressive background slowing and multifocal epileptiform abnormalities, occurring asynchronously, predominantly in the temporo-parieto-occipital regions, either at epilepsy onset (6/20 [30%]) or after 1 to 7 months (14/20 [70%]). EEG abnormalities consisted of highamplitude sharp waves and trains of delta and beta activity, increased during sleep (figure 1). The progressive increase of posterior temporo-occipital beta/delta activity paralleled worsening of visual impairment. Source analysis indicated a generator deep in the occipitoparietal regions ( figure 1 ). An overnight sleep EEG was recorded in 10 patients, revealing a regularly organized sleep macrostructure.
Seizures were captured on video-EEG in 21 of 22 patients. FS were the most common seizure type. We did not record any true generalized TCS, only focal-to-bilateral TCS, and the reported "absence" seizures were all FS, except for patient 14, who had myoclonic absences from age 10 months. FS were typically prolonged, lasting up to 20 minutes, with (1) prominent hypomotor and autonomic symptoms (flushing, tachycardia, and/or bradycardia), often with lateral eye deviation, mouth or eyelid myoclonia, apnea, and cyanosis, followed at times by (2) asymmetric tonic or tonic-vibratory phase and (3) prolonged clonic or hemiclonic manifestations with or without (4) bilateral TCS ( figure 2 and video 1) . The hypomotor phase, which often passed unnoticed, could lead directly to a bilateral TCS. The EEG correlate of FS showed 2 spread patterns: (1) posterior temporal rhythmic activity (at seizure onset and end), with slow spread sometimes with intraictal migration from one hemisphere to the other or, less frequently, (2) diffuse EEG desynchronization, followed by posterior rhythmic spiking and spreading to the frontocentral regions (figure 2).
In 7 children (32%), we documented episodes resembling spasms, often asymmetric and followed by hyperkinetic manifestations (5-10 seconds) (video 2). They were recorded during both wakefulness and sleep, occurring independently or in clusters after an FS. The EEG correlate was diffuse low-voltage fast activity, sometimes preceded by a high-voltage sharp and slow wave complex, consistent with a tonic seizure pattern ( figure 3A ). Seven patients (32%) had segmental erratic jerks, consistent with cortical myoclonus, often occurring almost continuously (figure 1). Two patients also had tongue (3) and laryngeal myoclonus (16) . In 5 patients, we recorded myoclonic NCSE, with an EEG correlate consisting of triphasic sharp waves predominant in the central or rolandic regions (figure 3B). Two children had recurrent paroxysmal autonomic manifestations with hyperventilation, sweating, tachycardia (patient 3), or change of pupil size (patient 4), without EEG correlate.
Electroretinograms were normal in 4 of 5 cases (11, 12, 16, 21) and low amplitude in one (7). Visual evoked potentials were normal in 4 patients (1, 6, 12, 16), showed reduced amplitude in 2 (7, 18) , and increased latency in 2 (7, 14) . Somatosensory evoked potentials were normal in 3 patients (1, 6, 11) and extinct in one (14) . Sensory and motor nerve conduction studies in 2 children (5, 8) were normal.
MRI findings
In 20 of 22 patients (91%), cerebral MRI was normal or showed minor abnormalities at epilepsy onset. Two (13, 21) had mild brain atrophy at age 10 months. In 10 patients (45%) (1, 3-7, 10-12, 16), follow-up MRI scans showed progressive cortical and subcortical atrophy ( figure 4, patient 3) . One patient (4) had sequelae of a choroid plexus and cerebellar hemorrhage. In 3 patients (3, 4, 16), hyperintensity of the posttrigonal white matter on T2-weighted imaging was seen, along with restricted diffusion in the optic radiations (figure 4, patients 4 and 16). Magnetic resonance spectroscopy was abnormal in 2 of 6 patients, showing nonspecific posterior abnormalities (patient 7) or a reduced N-acetylaspartate/ creatine ratio, and increased choline/creatine ratio in the parietal retroventricular white matter, likely due to cell membrane turnover ( figure 4, patient 16 ).
Genetic investigations
Twenty-one of 22 patients (95%) carried a de novo heterozygous missense variant in SCN8A (table 1) . We identified 16 different missense variants; all were predicted to be damaging by one or more prediction tools (PolyPhen-2, SIFT, MutationTaster) and absent in control databases (ExAC, gnomAD). Patient 8 carried a de novo splice-site variant, predicted to cause the inframe deletion Pro1428_Lys1473del and absent in control databases (ExAC, gnomAD). The splice-site variant and 9 
Discussion
We report a description of the phenotype of EIEE related to de novo heterozygous variant in SCN8A (EIEE13, OMIM #614558).
Twenty-one of 22 patients had a missense variant, whereas one (previously published) patient had a de novo splice-site variant, whose predicted product is a frame deletion. Seven missense variants have not previously been associated with SCN8A-DEE, 5 of them being located into domains relevant to protein function ( figure 4) . Nine of the missense variants 17 have been previously described. 8, 9, [14] [15] [16] However, 4 patients with these mutations are unpublished (3, 18, 19, 22) . Four missense variants recurred in 2 to 3 patients each in the present study (p.GLy1475Arg, p.Ala1491Val, p.Ala1650Thr, p.Arg1872Trp). We could not find evident genotype-phenotype correlations, both among the present group of patients and compared with the benign cases previously described. 3 From birth, 73% of patients had developmental delay and/or other neurologic signs (23%). Epilepsy onset, at a median age of 4 months (range 1-36 months), was typically stormy (73%), but a more gradual and progressive course was also seen (27%). The finding of rhythmic fetal or neonatal abnormal movements in 2 children suggested a possible prenatal subtle onset of epilepsy or movement disorder. 18 The interictal EEG was normal or mildly abnormal in 91% of patients at epilepsy onset, then deteriorated, as observed previously, 9 recapitulating the murine model (heterozygous Scn8a N1768D/+ mice). 19 Despite the severe evolution of the disease, the interictal EEG was often normal or almost normal for several months after epilepsy onset. 20 With time, multifocal interictal epileptiform discharges, predominantly in the posterior quadrants, together with progressively increasing delta activity with superimposed bursts of beta activity appeared, as observed previously. 9 This peculiar EEG pattern (figure 1) has not been reported in SCN2A-related epileptic encephalopathy and differs from EEG abnormalities in epilepsy syndromes within the generalized epilepsy with febrile seizures plus spectrum with SCN1A mutations, 21 and might be a marker of EIEE13.
The source analysis of the beta-delta activity suggests a generator deep in the occipitoposterior temporal regions. In a few patients with cortical visual impairment, the MRI showed a restriction and hyperintensity of the visual tract and the magnetic resonance spectroscopy an alteration at the level of the retroventricular white matter, reflecting neuroaxonal damage and abnormal cellular membrane turnover, as in the Likewise, in infants with perinatal brain lesions and in children with West syndrome, the visual impairment correlates better with the EEG than with the brain MRI findings.
22,23
In contrast to the description of a disturbed sleep pattern in the homozygous null mice lacking functional NaV1.6, 24 we failed to document alterations of sleep macrostructure. The disease mechanisms of the homozygous loss-of-function mice are probably different from the heterozygous, likely gain-offunction pathogenic variants in our patients.
Video-EEG recordings documented FS with posterior EEG onset and slow spreading, sometimes with intraictal migration of the epileptic discharge from one hemisphere to the other. The early clinical semiology included (1) hypomotor and autonomic symptoms, eye deviation, and often cyanosis, eventually evolving to (2) asymmetric tonic and (3) (hemi)-clonic manifestations with or without (4) bilateral TCS. All recorded TCS were focal onset seizures that became bilateral; in some cases, seizure onset was not recognized. FS were often misclassified as absences, tonic, or generalized tonic-clonic seizures, or even unrecognized, depending on the prominence of motor manifestations. True myoclonic absence seizures were recorded in only one patient (14) . The mouse model of SCN8A-related epilepsy exhibits diffuse spike-waves and absence epilepsy, suggesting that SCN8A might cause generalized epilepsy as well. 25 Children with SCN8A-DEE have been reported as having both FS and generalized seizures. 8, 9 Here, we classified seizures based on video-EEG recordings, documenting focal to bilateral TCS, without true generalized TCS. We therefore conclude that SCN8A-DEE presents as a (multi)focal encephalopathy rather than a generalized one. In a few patients, we observed intraictal migration of the FS from one hemisphere to the other, similar to what is observed in SCN2A encephalopathy. 26 FS were characterized by posterior temporo-occipital onset and offset, very long duration (several minutes), and clustering. NCSE was also common (64%), often having a myoclonic component. These features have not been previously described and might be characteristic of, although not specific to, SCN8A-DEE.
Cortical myoclonus (36%) and clusters of spasm-like episodes (36%) (figure 3) were relatively common features in SCN8A-DEE. This is recapitulated in the mouse model of SCN8A-DEE that shows diffuse spike-or polyspikes-and-slow wave discharges, often accompanied by spasms or myoclonic jerks. 19 All seizures were extremely drug-resistant, with only 2 patients achieving periods of seizure control. The most effective AEDs were phenytoin, carbamazepine, and oxcarbazepine, usually at supratherapeutic doses. Both seizure clusters and NCSE were responsive to benzodiazepines. Levetiracetam was constantly ineffective or even worsened seizures. The ketogenic diet was somewhat effective in 5 of 9 patients (55%), and in one patient succeeded in interrupting refractory NCSE. Thus, the ketogenic diet, effective in 75% of patients with Dravet syndrome, 27 is also valuable in SCN8A-DEE. Steroids provided some benefit acutely and for control of spasms. Cannabinoids were tried in 2 children, with no effects.
In all patients, seizure onset was followed by developmental regression, with eventual severe to profound intellectual disability, absent speech (91%), worsening pyramidal/ extrapyramidal signs, dystonia and choreoathetosis (55%), progressive visual impairment resulting in cortical blindness (77%), and severe gastrointestinal problems (68%) with enteral feeding (45%). Progressive microcephaly and spontaneous bone fractures were occasionally reported. Recently, bone loss syndrome with elevated bone reabsorption has been associated with SCN8A-DEE. 28 These clinical features are distinguishable from most of the other common genetic causes of DEE (table 2 for an overview) and bear some similarity with those of SCN2A encephalopathy. 29 Cortical blindness has not been described in SCN2A encephalopathy but may be a common feature of severe encephalopathies with different etiologies.
During early childhood, 4 patients died in the context of profound neurologic deterioration and uncontrolled daily, prolonged seizures. Increased precocious death rate, because of SUDEP, has been reported 2, 13, 30, 31 to occur in about 10% of patients with SCN8A. 12 Convulsive seizures leading to cardiac arrest and ultimately to SUDEP have been documented in a mouse model with a gain-of-function SCN8A mutation. [32] [33] [34] [35] In our cohort, we did not document "critical" ECG alterations during the seizures, whereas irregular breathing, cyanosis, and brady-/tachycardia were common. The prominent autonomic ictal manifestations and the prolonged seizure duration with frequent evolution to bilateral TCS may be risk factors for ictal death. However, none of these deaths were unexpected. Death occurred in early childhood, within a critical age (2-5 years) at which patients with SCN8A-DEE experience progressive worsening of their epilepsy and neurologic condition, rendering them susceptible to respiratory distress. Uncontrolled epilepsy, severe neurologic compromise, and the relentless severe infirmity likely contributed to the fatal outcome, suggesting that there are causes other than SUDEP for death in SCN8A-DEE.
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